Related Experiment Video
Updated: Jul 17, 2026

07:34
FISH for Pre-implantation Genetic Diagnosis
Published on: February 23, 2011
[Prenatal screening and diagnostics after infertility treatment]
Anne Cathrine R Gjerris1, Anne Loft, Anja B Pinborg
1Rigshospitalet, Juliane Marie Centeret, Ultralydklinikken. ac@gjerris.dk
Ugeskrift for Laeger
|February 7, 2007
Summary
First-trimester screening is a suitable option for women pregnant after infertility treatment. Further research is needed to determine if adjustments are required for biochemical markers in prenatal screening.
Area of Science:
- Obstetrics and Gynecology
- Prenatal Diagnostics
- Maternal-Fetal Medicine
Context:
- Women undergoing infertility treatment often have pregnancies with increased risks.
- These pregnancies are associated with advanced maternal age and higher risks of chromosomal abnormalities like Down's syndrome.
- There is a strong preference among these women to avoid invasive prenatal diagnostic procedures.
Purpose:
- To evaluate the suitability of first-trimester screening for pregnancies resulting from infertility treatment.
- To address the specific needs and concerns of women undergoing assisted reproductive technologies.
- To determine the efficacy and potential modifications of prenatal screening methods in this population.
Summary:
- First-trimester screening presents an acceptable option for prenatal screening in women pregnant after infertility treatment.
- This group has distinct risk profiles, including advanced maternal age and increased congenital malformation risks.
- The review suggests first-trimester screening is viable, but highlights the need for further studies on biochemical marker adjustments.
Impact:
- Provides evidence-based guidance for clinicians managing pregnancies conceived via infertility treatments.
- Informs patient counseling regarding prenatal screening options and associated risks.
- Highlights areas for future research to optimize prenatal care for this growing patient demographic.
Related Concept Videos
Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
In Vitro Fertilization
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Preventive Healthcare Services
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:

